NY S07499 | 2021-2022 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Engrossed on May 24 2022 - 50% progression, died in committee
Action: 2022-05-24 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Amended) [HTML]
Status: Engrossed on May 24 2022 - 50% progression, died in committee
Action: 2022-05-24 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Amended) [HTML]
Summary
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.
Title
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.
Sponsors
Roll Calls
2022-05-24 - Senate - Senate Floor Vote - Final Passage (Y: 48 N: 13 NV: 0 Abs: 2) [PASS]
2022-05-09 - Senate - Senate Health Committee Vote (Y: 9 N: 5 NV: 0 Abs: 1) [PASS]
2022-05-09 - Senate - Senate Health Committee Vote (Y: 9 N: 5 NV: 0 Abs: 1) [PASS]
History
Date | Chamber | Action |
---|---|---|
2022-05-24 | Assembly | referred to health |
2022-05-24 | Senate | DELIVERED TO ASSEMBLY |
2022-05-24 | Senate | PASSED SENATE |
2022-05-17 | Senate | ADVANCED TO THIRD READING |
2022-05-17 | Senate | AMENDED 7499B |
2022-05-16 | Senate | 2ND REPORT CAL. |
2022-05-11 | Senate | 1ST REPORT CAL.1338 |
2022-05-05 | Senate | PRINT NUMBER 7499A |
2022-05-05 | Senate | AMEND (T) AND RECOMMIT TO HEALTH |
2022-01-05 | Senate | REFERRED TO HEALTH |
2021-11-03 | Senate | REFERRED TO RULES |
Same As/Similar To
A00663 (Same As) 2022-05-19 - print number 663b